Avasopasem Manganese

Preferred Label : Avasopasem Manganese;

NCIt definition : A mimetic of the enzyme superoxide dismutase (SOD) that may potentially be used to reduce oral mucositis and esophagitis associated with radiation therapy and chemoradiotherapy. Upon administration, avasopasem manganese may mimic native SODs and catalyze the formation of molecular oxygen and hydrogen peroxide from the burst of superoxide anion present in the irradiated tissues upon radiation and/or induced by chemotherapy. This may decrease the damage of radiation and/or chemotherapy to normal tissues.;

UNII : EY1WA413UL;

InChIKey : WXEMWBBXVXHEPU-NDOCQCNASA-L;

CAS number : 435327-40-5;

Molecule name : GC 4419; GC-4419;

NCI Metathesaurus CUI : CL1382133;

Details

Origin ID

C169797;

UMLS CUI

C5392508;

Automatic exact mappings (from CISMeF team)
- avasopasem manganese [MeSH concept]
- avasopasem manganese [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- avasopasem manganese [MeSH Supplementary Concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients